Matthew J Glasgow1, Richard Edlin2, Jane E Harding3. 1. Liggins Institute, University of Auckland, Auckland, New Zealand. 2. School of Population Health, University of Auckland, Auckland, New Zealand. 3. Liggins Institute, University of Auckland, Auckland, New Zealand. Electronic address: j.harding@auckland.ac.nz.
Abstract
OBJECTIVE: To evaluate the long-term costs and impact on quality of life of using prophylactic dextrose gel in patients at increased risk of developing neonatal hypoglycemia. STUDY DESIGN: A cost-utility analysis was performed from the perspective of the health system, using a decision tree to model the long-term clinical outcomes of neonatal hypoglycemia, including cerebral palsy, epilepsy, vision disturbances, and learning disabilities, in patients at increased risk of neonatal hypoglycemia who received prophylactic dextrose gel vs standard care. Model parameters including likelihoods of hypoglycemia and admission to a neonatal intensive care unit, were based on the pre-Hypoglycemia Prevention with Oral Dextrose Study. Estimations of the likelihood of long-term condition(s), and their costs, were based on review of published literature. RESULTS: Patients who received prophylactic dextrose gel incurred costs to the health system of around US $14 000 over an 18-year time horizon, accruing 11.25 quality-adjusted life-years, whereas those who did not receive prophylactic treatment incurred cost of around $16 000 and experienced a utility of 11.10 quality-adjusted life-years. CONCLUSIONS: A prophylactic strategy of using dextrose gel in infants at increased risk of neonatal hypoglycemia is likely to be cost effective compared with standard care, to reduce the direct costs to the health system over an 18-year time horizon, and improve quality of life.
OBJECTIVE: To evaluate the long-term costs and impact on quality of life of using prophylactic dextrose gel in patients at increased risk of developing neonatal hypoglycemia. STUDY DESIGN: A cost-utility analysis was performed from the perspective of the health system, using a decision tree to model the long-term clinical outcomes of neonatal hypoglycemia, including cerebral palsy, epilepsy, vision disturbances, and learning disabilities, in patients at increased risk of neonatal hypoglycemia who received prophylactic dextrose gel vs standard care. Model parameters including likelihoods of hypoglycemia and admission to a neonatal intensive care unit, were based on the pre-Hypoglycemia Prevention with Oral Dextrose Study. Estimations of the likelihood of long-term condition(s), and their costs, were based on review of published literature. RESULTS: Patients who received prophylactic dextrose gel incurred costs to the health system of around US $14 000 over an 18-year time horizon, accruing 11.25 quality-adjusted life-years, whereas those who did not receive prophylactic treatment incurred cost of around $16 000 and experienced a utility of 11.10 quality-adjusted life-years. CONCLUSIONS: A prophylactic strategy of using dextrose gel in infants at increased risk of neonatal hypoglycemia is likely to be cost effective compared with standard care, to reduce the direct costs to the health system over an 18-year time horizon, and improve quality of life.
Authors: Christopher J D McKinlay; Jane M Alsweiler; Nicola S Anstice; Nataliia Burakevych; Arijit Chakraborty; J Geoffrey Chase; Gregory D Gamble; Deborah L Harris; Robert J Jacobs; Yannan Jiang; Nabin Paudel; Ryan J San Diego; Benjamin Thompson; Trecia A Wouldes; Jane E Harding Journal: JAMA Pediatr Date: 2017-10-01 Impact factor: 16.193
Authors: Emily W Y Tam; Elysa Widjaja; Susan I Blaser; Daune L Macgregor; Prakash Satodia; Aideen M Moore Journal: Pediatrics Date: 2008-09 Impact factor: 7.124
Authors: Taygen Edwards; Gordon Liu; Joanne E Hegarty; Caroline A Crowther; Jane Alsweiler; Jane E Harding Journal: Cochrane Database Syst Rev Date: 2021-05-17
Authors: Jane E Harding; Joanne E Hegarty; Caroline A Crowther; Richard P Edlin; Gregory D Gamble; Jane M Alsweiler Journal: PLoS Med Date: 2021-01-28 Impact factor: 11.069